Patent Proceedings: Merck’s Favorable Result and Amgen’s Supreme Court Case – BioSpace

23rd September 2022

Patent Proceedings: Merck’s Favorable Result and Amgen’s Supreme Court Case BioSpace

OPUS IP on X (formerly Twitter)…

Twitter feed is not available at the moment.

RECENT PATENT NEWS…

PATENT—Fed. Cir.: Patent licensee can pursue Broadcom infringement suit without university patent owner - VitalLaw.com
Can the Patent System Keep Pace with Life Sciences Innovation? - IPWatchdog.com
OSD granted patent for biometric barcode security and authentication - Biometric Update
Comcast Can't Relitigate Invalidity Issue In Patent Suit - Law360

UK BUSINESS NEWS…

Nvidia boss says AI 'doesn't need new laws' as safety concerns grow
US borrowing costs hit highest level since 2007
State pension likely to top £13,000 a year as UK wage growth slows to 3.9%
State pension likely to top £13,000 a year as UK wage growth slows to 3.9%

Designed by Industrial Action

Copyright © 2026 OPUS IP Limited. All Rights Reserved

OPUS IP Limited: COMPANY & OTHER LEGAL INFORMATION